222 related articles for article (PubMed ID: 6479819)
1. [Intravenous gamma globulin therapy. Measurement of circulating immune complexes and complement factors].
Wahn V
Fortschr Med; 1984 Aug; 102(31-32):795-8. PubMed ID: 6479819
[TBL] [Abstract][Full Text] [Related]
2. Evidence of persistent IgA/IgG circulating immune complexes associated with activation of the complement system in serum of a patient with common variable immune deficiency: anaphylactic reactions to intravenous gammaglobulin.
Wahn V; Good RA; Gupta S; Pahwa S; Day NK
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():49-58. PubMed ID: 6203331
[TBL] [Abstract][Full Text] [Related]
3. Adverse reactions in selected patients following intravenous infusions of gamma globulin.
Day NK; Good RA; Wahn V
Am J Med; 1984 Mar; 76(3A):25-32. PubMed ID: 6231860
[TBL] [Abstract][Full Text] [Related]
4. [The pathogenesis of immune complexes and the clinical intravenous use of IgG and enzyme-treated IgG preparation].
Sedlacek HH; Seiler FR
Beitr Infusionther Klin Ernahr; 1982; 9():80-94. PubMed ID: 6216882
[No Abstract] [Full Text] [Related]
5. [Comparison of the complement-binding activity of model immune complexes of different molecular weights].
Konstantinova NA; Tumanova IA; Lavrent'ev VV; Petrov RV
Biull Eksp Biol Med; 1984 May; 97(5):583-5. PubMed ID: 6722337
[TBL] [Abstract][Full Text] [Related]
6. Study of complement-mediated anaphylaxis in humans. The role of IgG subclasses (IgG1 and/or IgG4) in the complement-activating capacity of immune complexes.
Bergamaschini L; Santangelo T; Faricciotti A; Ciavarella N; Mannucci PM; Agostoni A
J Immunol; 1996 Feb; 156(3):1256-61. PubMed ID: 8558005
[TBL] [Abstract][Full Text] [Related]
7. [Complement-binding capacity of aggregated immunoglobulins of different molecular weights].
Konstantinova NA; Ostreĭko KK; Tumanova IA; Lavret'ev VV; Petrov RV
Biull Eksp Biol Med; 1982 Dec; 94(12):73-5. PubMed ID: 7150770
[TBL] [Abstract][Full Text] [Related]
8. Intravenous therapy with gamma globulin.
Dwyer JM
Adv Intern Med; 1987; 32():111-35. PubMed ID: 3548246
[TBL] [Abstract][Full Text] [Related]
9. [Significance of systemic immunodeficiencies and the autoimmune process in the pathogenesis of chronic tonsillitis].
Siegel G; Malberg K; Barthelmes H
Allerg Immunol (Leipz); 1984; 30(2):91-103. PubMed ID: 6237561
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies, immunoglobulins, complement and circulating immune complexes in acute malaria.
Jhaveri KN; Ghosh K; Mohanty D; Parmar BD; Surati RR; Camoens HM; Joshi SH; Iyer YS; Desai A; Badakere SS
Natl Med J India; 1997; 10(1):5-7. PubMed ID: 9069696
[TBL] [Abstract][Full Text] [Related]
11. Rapid immune adherence reactivity of nascent, soluble antibody/DNA immune complexes in the circulation.
Edberg JC; Kujala GA; Taylor RP
J Immunol; 1987 Aug; 139(4):1240-4. PubMed ID: 3611789
[TBL] [Abstract][Full Text] [Related]
12. [The anticomplementary activity of 2 intravenous gamma globulin preparations in children with acute lymphatic leukemia].
Wahn V; von Kries R; Ebell W; Jürgens H; Göbel U
Immun Infekt; 1984 Apr; 12(2):115-8. PubMed ID: 6442915
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of antigen complexed with antibody. I. Role of different isotypes.
Farkas AI; Medgyesi GA; Füst G; Miklós K; Gergely J
Immunology; 1982 Mar; 45(3):483-92. PubMed ID: 7061107
[TBL] [Abstract][Full Text] [Related]
14. Posttransfusion anaphylactic reactions in a patient with severe von Willebrand disease: role of complement and alloantibodies to von Willebrand factor.
Bergamaschini L; Mannucci PM; Federici AB; Coppola R; Guzzoni S; Agostoni A
J Lab Clin Med; 1995 Mar; 125(3):348-55. PubMed ID: 7897302
[TBL] [Abstract][Full Text] [Related]
15. Complement and humoral immune parameters in bone marrow transplant recipients: effects of intravenous immunoglobulin administration.
Späth PJ; Baumgartner C; Gratwohl A; Doran JE; Elisa A; Bachmann P; Scherz R; Berger C; Morell A; Tichelli A
Transplant Proc; 1989 Feb; 21(1 Pt 3):3064-6. PubMed ID: 2495696
[No Abstract] [Full Text] [Related]
16. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Vanes LA
Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
[TBL] [Abstract][Full Text] [Related]
17. [Indications for clinico-immunologic testing methods].
Z Erkr Atmungsorgane; 1982; 159(3):309-21. PubMed ID: 6191446
[No Abstract] [Full Text] [Related]
18. Role of the complement system in antigen-induced bronchoconstriction and changes in blood pressure in the guinea pig.
Regal JF; Fraser DG; Toth CA
J Pharmacol Exp Ther; 1993 Nov; 267(2):979-88. PubMed ID: 8246173
[TBL] [Abstract][Full Text] [Related]
19. Consensus conference evaluates key issues concerning use of intravenous immune globulin.
Clin Pharm; 1990 Jul; 9(7):489, 492-3. PubMed ID: 2198122
[No Abstract] [Full Text] [Related]
20. [Prevention and therapy with immunoglobulin SRK].
Schnoz M; Ryser DH; Barandun S; Eckmann L
Helv Chir Acta; 1979 May; 46(1-2):111-3. PubMed ID: 38227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
